150 related articles for article (PubMed ID: 38189531)
1. A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).
Varma A; Todinca MS; Eichinger K; Heininger S; Dilek N; Martens W; Tawil R; Statland J; Kissel JT; McDermott MP; Heatwole C
Muscle Nerve; 2024 Mar; 69(3):362-367. PubMed ID: 38189531
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.
LoRusso S; Johnson NE; McDermott MP; Eichinger K; Butterfield RJ; Carraro E; Higgs K; Lewis L; Mul K; Sacconi S; Sansone VA; Shieh P; van Engelen B; Wagner K; Wang L; Statland JM; Tawil R;
BMC Neurol; 2019 Sep; 19(1):224. PubMed ID: 31506080
[TBL] [Abstract][Full Text] [Related]
3. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.
Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C
Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084
[TBL] [Abstract][Full Text] [Related]
4. A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.
Neurology; 1997 Jan; 48(1):38-46. PubMed ID: 9008491
[TBL] [Abstract][Full Text] [Related]
5. Facioscapulohumeral muscular dystrophy functional composite outcome measure.
Eichinger K; Heatwole C; Iyadurai S; King W; Baker L; Heininger S; Bartlett A; Dilek N; Martens WB; Mcdermott M; Kissel JT; Tawil R; Statland JM
Muscle Nerve; 2018 Jan; ():. PubMed ID: 29381807
[TBL] [Abstract][Full Text] [Related]
6. Correlation between whole body muscle MRI and functional measures in paediatric patients with facioscapulohumeral muscular dystrophy.
Woodcock IR; de Valle K; Varma N; Kean M; Ryan MM
Neuromuscul Disord; 2023 Jan; 33(1):15-23. PubMed ID: 36522253
[TBL] [Abstract][Full Text] [Related]
7. Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.
Mul K; Heatwole C; Eichinger K; Dilek N; Martens WB; Van Engelen BGM; Tawil R; Statland JM
Muscle Nerve; 2018 Aug; 58(2):213-218. PubMed ID: 29543984
[TBL] [Abstract][Full Text] [Related]
8. Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy.
Wang LH; Leung DG; Wagner KR; Lowry SJ; McDermott MP; Eichinger K; Higgs K; Walker M; Lewis L; Martens WB; Mul K; Sansone VA; Shieh P; Elsheikh B; LoRusso S; Butterfield RJ; Johnson N; Preston MR; Messina C; Carraro E; Tawil R; Statland J;
Neuromuscul Disord; 2023 Sep; 33(9):63-68. PubMed ID: 37400350
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy.
Wang LH; Shaw DWW; Faino A; Budech CB; Lewis LM; Statland J; Eichinger K; Tapscott SJ; Tawil RN; Friedman SD
BMC Musculoskelet Disord; 2021 Mar; 22(1):262. PubMed ID: 33691664
[TBL] [Abstract][Full Text] [Related]
10. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
[TBL] [Abstract][Full Text] [Related]
11. Reliability and validity of the FSHD-composite outcome measure in childhood facioscapulohumeral dystrophy.
de Valle K; Dobson F; Woodcock I; Carroll K; Ryan MM; Heatwole C; Eichinger K; McGinley JL
Neuromuscul Disord; 2021 Aug; 31(8):706-715. PubMed ID: 34210539
[TBL] [Abstract][Full Text] [Related]
12. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.
Statland JM; McDermott MP; Heatwole C; Martens WB; Pandya S; van der Kooi EL; Kissel JT; Wagner KR; Tawil R
Neuromuscul Disord; 2013 Apr; 23(4):306-12. PubMed ID: 23406877
[TBL] [Abstract][Full Text] [Related]
13. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging.
Monforte M; Laschena F; Ottaviani P; Bagnato MR; Pichiecchio A; Tasca G; Ricci E
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1258-1265. PubMed ID: 31668022
[TBL] [Abstract][Full Text] [Related]
14. Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.
Ghasemi M; Emerson CP; Hayward LJ
Cells; 2022 Feb; 11(4):. PubMed ID: 35203336
[TBL] [Abstract][Full Text] [Related]
15. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
[TBL] [Abstract][Full Text] [Related]
16. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy.
Gros M; Nunes AM; Daoudlarian D; Pini J; Martinuzzi E; Barbosa S; Ramirez M; Puma A; Villa L; Cavalli M; Grecu N; Garcia J; Siciliano G; Solé G; Juntas-Morales R; Jones PL; Jones T; Glaichenhaus N; Sacconi S
J Neuromuscul Dis; 2022; 9(1):83-93. PubMed ID: 34459413
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.
Kissel JT; McDermott MP; Mendell JR; King WM; Pandya S; Griggs RC; Tawil R;
Neurology; 2001 Oct; 57(8):1434-40. PubMed ID: 11673585
[TBL] [Abstract][Full Text] [Related]
18. Electrical impedance myography in facioscapulohumeral muscular dystrophy.
Statland JM; Heatwole C; Eichinger K; Dilek N; Martens WB; Tawil R
Muscle Nerve; 2016 Oct; 54(4):696-701. PubMed ID: 26840230
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of the patient-reported "Facial Function Scale" for facioscapulohumeral muscular dystrophy.
Mul K; Wijayanto F; Loonen TGJ; Groot P; Vincenten SCC; Knuijt S; Groothuis JT; Maal TJJ; Heskes T; Voermans NC; Engelen BGMV
Disabil Rehabil; 2023 May; 45(9):1530-1535. PubMed ID: 35575310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
